NL-OMON39974
Completed
N/A
Immunity after yellow fever vaccination in HIV positive travelers - YELLAR study - YELLAR study
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Yellow Fever Infection
- Sponsor
- Academisch Medisch Centrum
- Enrollment
- 60
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\> 18 years
- •Indication for first yellow fever vaccination
- •Travel to a yellow fever endemic area within one year
- •Stable CD4 counts between 200 and 500 for at least two one year (2 measurements at half yearly clinical visits) and certain travel to yellow fever endemic area, even if travel has not been planned.
Exclusion Criteria
- •\< 18 years
- •Previous yellow fever vaccination
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not Yet Recruiting
N/A
Immunity induced by yellow fever vaccination in the elderly (60yrs or older)travellergele koorts, oudere, reizen, neutraliserende antistoffen, bijwerkingenyellow fever, elderly, travel, neutralizing antibodies, adverse eventsNL-OMON20831A.H.E. Roukens en L.G. Visser60
Completed
N/A
ong-term immunity after Yellow fever vaccinatioYellow feverJPRN-UMIN000040526Tokyo Medical University Hospital Travellers' Medical Center50
Completed
N/A
Immunity after yellow fever vaccination in travelers using immunosuppressive medication-YETI studyYellow Fever infection10047438NL-OMON37037Academisch Medisch Centrum75
Active, Not Recruiting
N/A
Immunity of the Vaccine against Yellow Fever in patients taking medications that affect the immune systemnspecified rheumatoid arthritisM06.9RBR-946bv5Centro de Pesquisas René Rachou- FIOCRUZ
Completed
Phase 3
The Yellow Fever Vaccine Immunity in HIV Infected Patients : Development of New Assays for Virological and Immunological Monitoring in HIV Infected Patient.HIV InfectionYellow FeverNCT01426243French National Agency for Research on AIDS and Viral Hepatitis71